Please assess the completion status of the following clinical trial:

Trial Title: Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Diagnosis of asthma~* Reversibility \>12% after inhalation of 200 µg Salbutamol~* willingness and ability to complete daily record card on daily basis and to measure morning PEF on daily basis~* 80% compliance in diary card completion asthma control status: Uncontrolled based on the GOAL criteria~Exclusion criteria:~* Change of asthma medication during the last 4 weeks~* Asthma exacerbation characterized by use of oral corticoids during the last 3 months Pretreatment with inhaled corticosteroids more than 500 mcg Beclometasondipropionat or equivalent per day or other controller therapy during the last 3 months~* upper or lower respiratory tract infection during the RUN-IN period moderate or severe asthma exacerbation during the RUN-IN period~* Non compliance with use of Discus, PEF-meter and incomplete diary card data

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SFC 50/250 mcg (Type: EXPERIMENTAL): Participants received the combination product, fluticasone 250 microgram (mcg) plus salmeterol 50 mcg (SFC 50/250 mcg) for 12 weeks. Study treatment was received using DISKUS™ powder inhalers, one dose in morning and evening. Study medication was dispensed at visits 3, 4, and 5 for 30 days each. The participants were provided with salbutamol rescue medication if they developed acute asthmatic symptoms. This medication was provided in metered dose inhalers containing at least 200 puffs of 100 mcg salbutamol. Use of rescue medications was recorded in the participant's asthma diaries. Stable dosages of other concomitant medications were allowed if they had no impact on the outcome criteria.

Based on this trial design, predict the completion outcome and termination type (if applicable).